Cargando…
Modulation of MKNK2 alternative splicing by splice-switching oligonucleotides as a novel approach for glioblastoma treatment
The gene encoding the kinase Mnk2 (MKNK2) is alternatively spliced to produce two isoforms—Mnk2a and Mnk2b. We previously showed that Mnk2a is downregulated in several types of cancer and acts as a tumor suppressor by activation of the p38–MAPK stress pathway, inducing apoptosis. Moreover, Mnk2a ove...
Autores principales: | Mogilevsky, Maxim, Shimshon, Odelia, Kumar, Saran, Mogilevsky, Adi, Keshet, Eli, Yavin, Eylon, Heyd, Florian, Karni, Rotem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265459/ https://www.ncbi.nlm.nih.gov/pubmed/30329087 http://dx.doi.org/10.1093/nar/gky921 |
Ejemplares similares
-
Specific inhibition of splicing factor activity by decoy RNA oligonucleotides
por: Denichenko, Polina, et al.
Publicado: (2019) -
Hybridization-mediated off-target effects of splice-switching antisense oligonucleotides
por: Scharner, Juergen, et al.
Publicado: (2020) -
RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer
por: Jbara, Amina, et al.
Publicado: (2023) -
The small molecule Retro-1 enhances the pharmacological actions of antisense and splice switching oligonucleotides
por: Ming, Xin, et al.
Publicado: (2013) -
Intravitreal Injection of Splice-switching Oligonucleotides to Manipulate Splicing in Retinal Cells
por: Gérard, Xavier, et al.
Publicado: (2015)